Vivace Therapeutics, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
At Vivace, we're pioneering a new era of cancer therapeutics. Leveraging our industry-leading expertise in the intricate Hippo-YAP pathway – a critical regulator of cell proliferation, programmed cell death, and cell migration – we are developing a groundbreaking generation of YAP-TEAD transcription activity inhibitors. This innovative approach addresses fundamental mechanisms of cancer, representing a significant opportunity for superior patient outcomes and substantial market potential. For more information on the company, please visit the company website www.vivacetherapeutics.com. The company's scientific founders are Dr. Kun-liang Guan of UCSD, Dr. Bin Liu of UCSF and Dr. Sheng Ding of UCSF.